Bard Associates’s Sonoma Pharmaceuticals SNOA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,325
| Closed | -$341K | – | 178 |
|
|
2021
Q2 | $341K | Buy |
2,325
+10
| +0.4% | +$1.47K | 0.11% | 138 |
|
|
2021
Q1 | $344K | Hold |
2,315
| – | – | 0.12% | 130 |
|
|
2020
Q4 | $336K | Hold |
2,315
| – | – | 0.13% | 124 |
|
|
2020
Q3 | $388K | Sell |
2,315
-15
| -0.6% | -$2.51K | 0.21% | 107 |
|
|
2020
Q2 | $332K | Sell |
2,330
-271
| -10% | -$38.6K | 0.18% | 113 |
|
|
2020
Q1 | $255K | Sell |
2,601
-411
| -14% | -$40.3K | 0.19% | 110 |
|
|
2019
Q4 | $262K | Buy |
3,012
+1,783
| +145% | +$155K | 0.13% | 131 |
|
|
2019
Q3 | $142K | Sell |
1,229
-124
| -9% | -$14.3K | 0.07% | 147 |
|
|
2019
Q2 | $214K | Sell |
1,353
-56
| -4% | -$8.86K | 0.11% | 136 |
|
|
2019
Q1 | $239K | Sell |
1,409
-18
| -1% | -$3.05K | 0.12% | 138 |
|
|
2018
Q4 | $183K | Sell |
1,427
-444
| -24% | -$56.9K | 0.11% | 141 |
|
|
2018
Q3 | $492K | Sell |
1,871
-5
| -0.3% | -$1.32K | 0.23% | 112 |
|
|
2018
Q2 | $837K | Buy |
1,876
+54
| +3% | +$24.1K | 0.39% | 96 |
|
|
2018
Q1 | $1.21M | Sell |
1,822
-35
| -2% | -$23.2K | 0.6% | 70 |
|
|
2017
Q4 | $1.84M | Buy |
1,857
+1,176
| +173% | +$1.16M | 0.88% | 37 |
|
|
2017
Q3 | $639K | Sell |
681
-2
| -0.3% | -$1.88K | 0.3% | 103 |
|
|
2017
Q2 | $814K | Hold |
683
| – | – | 0.37% | 98 |
|
|
2017
Q1 | $881K | Sell |
683
-15
| -2% | -$19.3K | 0.41% | 90 |
|
|
2016
Q4 | $633K | Buy |
698
+57
| +9% | +$51.7K | 0.29% | 99 |
|
|
2016
Q3 | $501K | Sell |
641
-5
| -0.8% | -$3.91K | 0.24% | 108 |
|
|
2016
Q2 | $466K | Buy |
646
+3
| +0.5% | +$2.16K | 0.25% | 107 |
|
|
2016
Q1 | $553K | Sell |
643
-3
| -0.5% | -$2.58K | 0.32% | 98 |
|
|
2015
Q4 | $668K | Buy |
+646
| New | +$668K | 0.39% | 87 |
|
|
2014
Q3 | – | Sell |
-21
| Closed | -$59K | – | 173 |
|
|
2014
Q2 | $59K | Sell |
21
-198
| -90% | -$556K | 0.02% | 182 |
|
|
2014
Q1 | $742K | Sell |
219
-8
| -4% | -$27.1K | 0.31% | 109 |
|
|
2013
Q4 | $708K | Sell |
227
-26
| -10% | -$81.1K | 0.29% | 111 |
|
|
2013
Q3 | $623K | Buy |
253
+178
| +237% | +$438K | 0.28% | 119 |
|
|
2013
Q2 | $174K | Buy |
+75
| New | +$174K | 0.08% | 166 |
|